Lysophosphatidylcholine upregulates CD40 ligand expression in newly activated human CD4+ T cells

S Sakata-Kaneko1, Y Wakatsuki, T Usui

  • 1Department of Clinical Bio-regulatory Science, Kyoto University Graduate School of Medicine, Japan.

FEBS Letters
|September 17, 1998
PubMed

Insights

Lysophosphatidylcholine (lyso-PC) promotes T cell inflammation by increasing IFN-gamma and CD40L, impacting Th1/Th2 balance and atherosclerosis pathogenesis. This modified lipid plays a novel role in immune responses.

Area of Science:

  • Immunology
  • Lipid Metabolism
  • Atherosclerosis Research

Background:

  • Lysophosphatidylcholine (lyso-PC) accumulates in inflammatory conditions like atherosclerosis.
  • T cell infiltration is a hallmark of these disease states.

Purpose of the Study:

  • To investigate the effect of lyso-PC on CD4+ T cell function.
  • To explore the role of lyso-PC in modulating immune responses and T cell-mediated pathogenesis in atherosclerosis.

Main Methods:

  • Stimulation of CD4+ T cells with anti-CD3 antibody and recombinant CD80.
  • Treatment with lyso-PC to assess cytokine production and surface marker expression.

Main Results:

  • Lyso-PC significantly increased Interferon-gamma (IFN-gamma) production.
  • Lyso-PC enhanced CD40L expression on CD4+ T cells.
  • Interleukin-2 (IL-2) and Interleukin-4 (IL-4) production remained unaffected by lyso-PC.

Conclusions:

  • Lyso-PC can modulate CD4+ T cell functions, potentially propagating local inflammation.
  • Lyso-PC may play a role in selecting the Th1/Th2 immune response balance.
  • This modified lipid contributes to T cell-mediated pathogenesis in atherosclerosis.